JPM highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO platform delivering sustainable high growth Post author:admin Post published: January 27, 2026 Post category:uncategorized JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth You Might Also Like MS Australia urges government action on neurological research funding May 8, 2024 Research reveals shocking disparity in hearing aid access October 3, 2025 Newly discovered molecules accelerate the removal of immune-modulating enzyme January 7, 2026